Successive and cyclic oral contraceptive pill pretreatment improves IVF/ICSI outcomes of PCOS patients and ameliorates hyperandrogenism and antral follicle excess

References

• Ehrmann DA, Barnes RB, Rosenfield RL, et al. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 1999;22:141–6
   PubMed Web of Science ®Google Scholar
• Asuncion M, Calvo RM, San Millan JL, et al. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 2000;85:2434–8
   PubMed Web of Science ®Google Scholar
• Azziz R, Woods KS, Reyna R, et al. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004;89:2745–9
   PubMed Web of Science ®Google Scholar
• Diamanti-Kandarakis E, Kouli CR, Bergiele AT, et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 1999;84:4006–11
   PubMed Web of Science ®Google Scholar
• Goodarzi MO, Azziz R. Diagnosis, epidemiology, and genetics of the polycystic ovary syndrome. Best Pract Res Clin Endocrinol Metab 2006;20:193–205
   PubMed Web of Science ®Google Scholar
• Broekmans FJ, Knauff EA, Valkenburg O, et al. PCOS according to the Rotterdam consensus criteria: change in prevalence among WHO-II anovulation and association with metabolic factors. BJOG 2006;113:1210–17
   PubMed Web of Science ®Google Scholar
• Rajashekar L, Krishna D, Patil M. Polycystic ovaries and infertility: our experience. J Hum Reprod Sci 2008;1:65–72
   PubMedGoogle Scholar
• Macdougall MJ, Tan SL, Balen A, Jacobs HS. A controlled-study comparing patients with and without polycystic ovaries undergoing invitro fertilization. Hum Reprod 1993;8:233–7
   PubMed Web of Science ®Google Scholar
• Balen AH, Tan SL, Macdougall J, Jacobs HS. Miscarriage rates following invitro fertilization are increased in women with polycystic ovaries and reduced by pituitary desensitization with buserelin. Hum Reprod 1993;8:959–64
   PubMed Web of Science ®Google Scholar
• Wang JX, Davies MJ, Norman RJ. Polycystic ovarian syndrome and the risk of spontaneous abortion following assisted reproductive technology treatment. Hum Reprod 2001;16:2606–9
   PubMed Web of Science ®Google Scholar
• Winter E, Wang J, Davies MJ, Norman RJ. Early pregnancy loss following assisted reproductive technology treatment. Hum Reprod 2002;17:3220–3
   PubMed Web of Science ®Google Scholar
• Anderson RE, Stein AL, Paulson RJ, et al. Effects of norethindrone on gonadotropin and ovarian-steroid secretion when used for cycle programming during invitro fertilization. Fertil Steril 1990;54:96–101
   PubMed Web of Science ®Google Scholar
• Damario MA, Barmat L, Liu HC, et al. Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients. Hum Reprod 1997;12:2359–65
   PubMed Web of Science ®Google Scholar
• Palomba S, Falbo A, Orio F, et al. Pretreatment with oral contraceptives in infertile anovulatory patients with polycystic ovary syndrome who receive gonadotropins for controlled ovarian stimulation. Fertil Steril 2008;89:1838–42
   PubMed Web of Science ®Google Scholar
• Decanter C, Robin G, Thomas P, et al. First intention IVF protocol for polycystic ovaries: does oral contraceptive pill pretreatment influence COH outcome? Reprod Biol Endocrinol 2013;11:54–62
   PubMed Web of Science ®Google Scholar
• Rotterdam EA-SPcwg. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41–7
   PubMed Web of Science ®Google Scholar
• Hu XL, Feng C, Lin XH, et al. High maternal serum estradiol environment in the first trimester is associated with the increased risk of small-for-gestational-age birth. J Clin Endocrinol Metab 2014;99:2217–24
   PubMed Web of Science ®Google Scholar
• Norman RJ, Dewailly D, Legro RS, Hickey TE. Polycystic ovary syndrome. Lancet 2007;370:685–97
   PubMed Web of Science ®Google Scholar
• Osterholm EA, Hostinar CE, Gunnar MR. Alterations in stress responses of the hypothalamic-pituitary-adrenal axis in small for gestational age infants. Psychoneuroendocrinology 2012;37:1719–25
   PubMed Web of Science ®Google Scholar
• Taveras EM, Rifas-Shiman SL, Belfort MB, et al. Weight status in the first 6 months of life and obesity at 3 years of age. Pediatrics 2009;123:1177–83
   PubMed Web of Science ®Google Scholar
• Cohen BL, Katz M. Pituitary and ovarian function in women receiving hormonal contraception. Contraception 1979;20:475–87
   PubMed Web of Science ®Google Scholar
• de Ziegler D, Jaaskelainen AS, Brioschi PA, et al. Synchronization of endogenous and exogenous FSH stimuli in controlled ovarian hyperstimulation (COH). Hum Reprod 1998;13:561–4
   PubMed Web of Science ®Google Scholar
• Hoeger K, Davidson K, Kochman L, et al. The impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women in two randomized, placebo-controlled clinical trials. J Clin Endocrinol Metab 2008;93:4299–306
   PubMed Web of Science ®Google Scholar
• McGee EA, Hsueh AJW. Initial and cyclic recruitment of ovarian follicles 1. Endocr Rev 2000;21:200–14
   PubMed Web of Science ®Google Scholar
• Gougeon A. Dynamics of follicular growth in the human: a model from preliminary results. Hum Reprod 1986;1:81–7
   PubMed Web of Science ®Google Scholar